SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001469709-14-000484
Filing Date
2014-11-14
Accepted
2014-11-14 15:07:04
Documents
4
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 ENDO 10-Q 09/30/14 endo10q_093014apg.htm 10-Q 188966
2 GRAPHIC endo10q_093014apgac1001.jpg GRAPHIC 40283
3 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 10779
4 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3927
  Complete submission text file 0001469709-14-000484.txt   260608
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-176954 | Film No.: 141223331
SIC: 2834 Pharmaceutical Preparations